Hard gelatine capsule containing sodium iodide (Na¹³¹I), disodium hydrogene phosphate, sodium thiosulphate and sodium carbonate-bicarbonate buffer

 

 

MON.IYOT-131 0.37 – 7400 MBq ( 10µCi -200 mCi) oral capsule contains fission product radioactive iodine (¹³¹I) as an active substance which has 8.02 days half life and used for diagnosis and treatment of thyroid diseases.

 

16 µCi (0,59 MBq), 50 µCi (1,85 MBq), 100 µCi (3,7 MBq), 1 mCi (37 MBq), 2 mCi(74 MBq), 5 mCi (185 MBq), 10 mCi (370 MBq), 15 mCi (555 MBq), 20 mCi (740 MBq), 25 mCi (925 MBq), 30 mCi (1110 MBq), 50 mCi (1850 MBq), 75 mCi (2775 MBq), 100 mCi (3700 MBq), 125 mCi (4625 MBq), 150 mCi (5550 MBq), 175 mCi (6475 MBq), 200 mCi (7400 MBq)

 

Wednesday and Saturday

 

Next Wednesday (8 a.m.) after production or other days depending on request

 

30 days from the production

 

At room temperature below 25 ⁰C, in lead shield

 

A hard gelatine capsule in a polypropylene plastic tube within a lead shield and a polymethylmetalacrilate capsule ingestion apparatus in a box